Navigation Links
Memory Loss Linked to Cognitive Disorders

A new study has developed the first images of the physical changes in brain cells thought to underlie memory thus linking memory loss to cognitive disorders.

Earlier studies have established that a physiological effect known as long-term potentiation (LTP) encodes everyday forms of memory.

In neuroscience, LTP is an increase in the strength of a chemical synapse that lasts from minutes to several days. It is widely considered one of the major mechanisms by which memories are formed and stored in the brain.

The study was conducted by a team of researchers led by Christine M. Gall and Gary Lynch at the University of California, Irvine.

As part of the study, researchers collected brain tissues from rats and mice, which was kept alive in specially constructed equipment and induced LTP by stimulating synapses with a rhythm known to be critical to memory formation.

The brain slices were then sectioned and stained with one antibody that attaches to activated proteins involved with LTP and a second one that labels synapses. Newly developed microscopic methods were used to visualize and measure synapses that had both antibodies attached.

Researchers found with the images that the size and shape of synapses were changed by LTP.

It was shown how LTP deficiencies accompany the memory loss seen during the early stages of Huntingtons disease, an incurable neurodegenerative disease characterized by disturbances to memory and learning.

The way is now open to mapping where in the brain memories are laid down. Seeing memory-related physical changes to synapses means that we can at last use mouse models to test if the effects of retardation, aging and various cognitive disorders involve a specific, long-suspected defect in the connections between cortical neurons, Lynch said.

Scientists also found that LTP structures encoding memory were defective in mouse mod els of Huntingtons disease. They discovered that these synaptic defects could be fully reversed through treatment with a brain growth factor released at synapses.

Ampakines, a new class of drugs developed by researchers that is currently in clinical development for Alzheimers disease and ADHD, increase the levels of this growth factor and potentially emerge as a therapy for the cognitive problems associated with Huntingtons.

The findings of the study were published in the May issue of the Journal of Neuroscience.


'"/>




Related medicine news :

1. Memory problem? solve a crossword
2. Deep Sleep Doesnt Increase Memory
3. For a Better Memory
4. Memory loss associated with microbes
5. Memory loss always goes hand with Depression
6. Memory deprivation after operations
7. Sage Improves Memory
8. Memory said to automatically improve with age
9. Enzyme Associated with Memory
10. Enzyme Associated With Memory
11. New Drug Combination Found To Improve Memory in Alzheimer’s Patient
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... ... July 24, 2017 , ... Axiad IDS , a leading provider of ... with WALLIX to expand its solution to help government contractors more quickly ... number of ways to address the authentication requirements within NIST SP800-171, but no ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... fat (adipose) transfer systems announces the issuance of United States Patent Number 9,695,398 ... its adipose filtration technology. The '398 and '324 patents cover methods and ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... solution focused on delivering end-to-end sleep health care at scale, indicates record-breaking ... shows that adherence rates for positive airway pressure (PAP) therapy, the most widely ...
(Date:7/24/2017)... ... July 24, 2017 , ... Committed to eliminating clubfoot as ... 100,000 children in their treatment program. Clubfoot is a pervasive problem in the ... is limited or non-existent. Without intervention, these children are destined to grow up ...
(Date:7/24/2017)... ... 24, 2017 , ... On July 19th, the Chinese Academy ... the awarding ceremony was held successfully in Beijing. The State Health Planning Commission, ... system, and national Chinese medicine experts also attended the event, including more than ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... , July 13, 2017  New York City-based market research ... markets should be aware of.  From new products to new ... detailed in a recently completed study, Potential Pipeline Disruptors ... 1.  Age-Driven Growth - True ... been aware of the impact the growing population and, to ...
(Date:7/12/2017)...  Eli Lilly and Company (NYSE: LLY ) ... resolve pending patent litigation in the U.S. District Court for ... the Cialis ® (tadalafil) unit dose patent. This patent ... part of the agreement, Cialis exclusivity is now expected to ... "The unit dose patent for Cialis is valid and infringed ...
(Date:7/11/2017)... July 11, 2017  Bayer has awarded grants totaling more ... part of its prestigious Bayer Hemophilia Awards Program (BHAP). Four ... Philadelphia and Uniformed Services University of the ... the winners. Grant recipients were announced last night during a ... 2017 Congress, Berlin, Germany . ...
Breaking Medicine Technology: